TCT 2025
Don't Miss Unique Learning Opportunities at TCT
Visit Booth 1348
DanGer Shock RCT
New long-term data from the DanGer Shock RCT, published in the New England Journal of Medicine, validates the durability of original findings and confirms the survival benefit of Impella CP® heart pump increases year-over-year.1
Related Content
Explore Additional Resources
References
- Møller J, et al. Long Term Outcomes of the DanGer Shock Trial N Engl J Med 2025.
IMP-7055